To identify the intracellular site of ROS production in hRPE cells, we adopted a pharmacologic strategy previously used in HL60 cells using mitochondrial site-selective inhibitors.
22 23 Inhibition of the Qo site of respiratory complex III (cytochrome
bc 1) with stigmatellin blocked ROS production in cysteine-starved hRPE cells
(Fig. 1B) . The respiratory complex I inhibitor rotenone (1 μM) did not block ROS production in cysteine-starved or γGCL-inhibited hRPE cells (data not shown). This indicates that mitochondrial respiratory complex I is unlikely to be the predominant site of ROS generation in cysteine-starved hRPE cells, but cytochrome
bc 1 is a key ROS-producing site in these cells. Similar results have been obtained with the HL60 myeloid leukemic cell line
22 23 and in the leukemic lymphoid CEM cell line (Armstrong JS, Whiteman M, unpublished observations, 2004). The role of a functional cytochrome
bc 1 in ROS production in hRPE cells was further supported by the observation that cytochrome
bc 1 was fully active in cysteine-starved hRPE cells compared with control cells
(Fig. 1C) , whereas it was completely inhibited in stigmatellin-treated, cysteine-starved hRPE cells
(Fig. 1C) . This indicates that cytochrome
bc 1 activity is essential for ROS production after cysteine starvation, as in other cell systems.
22 23 In agreement with our results, Sun and Trumpower
33 recently found that cytochrome
bc 1 complexes from bovine heart and
Saccharomyces cerevisiae mitochondria generated significant levels of ROS which were blocked with stigmatellin. Taken together, these results indicate that (1) cytochrome
bc 1 is a critical mitochondrial respiratory site involved in ROS production in cysteine-starved hRPE cells and (2) cytochrome
bc 1 activity (i.e., electron flow through the complex) is crucial for ROS production. We found that stigmatellin preserved hRPE cell viability after cysteine starvation, as reported for other cells
(Fig. 1D) .
22 23